A HELICAL EPITOPE IN THE C4 DOMAIN OF HIV GLYCOPROTEIN-120

被引:26
作者
ROBEY, FA
KELSONHARRIS, T
ROLLER, PP
ROBERTGUROFF, M
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
[2] NCI,DIV CANC TREATMENT,MED CHEM LAB,BETHESDA,MD 20892
关键词
D O I
10.1074/jbc.270.41.23918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fourth conserved domain of the human immunodeficiency virus type 1 (HIV-1) envelope, the C4 region of glycoprotein 120 (gp120), is an amphipathic stretch of amino acids that, based on mutational analyses, constitutes a major component of the CD4 binding region in gp120. In the absence of crystallographic and NMR data on C4 in intact gp120, we sought to gain insight into C4's conformation and accessibility in gp120 by taking an immunochemical approach. In this study, a peptomer composed of a repeat peptide of C4 amino acids 419-436 from gp120 of HIV-1(MN) was synthesized for use as a conformationally constrained immunogen. Circular dichroism studies disclosed that the polymerized peptide, peptomer-(419-436), in 0.01 M Na2HPO4 buffer, pH 7.4, at 25 degrees C contained a dominant alpha-helical structure (53 +/- 1%) compared with 2 +/- 4% alpha-helical content for the monomeric peptide-(419-436). The peptomer in Ribi's adjuvant induced the production of rabbit antibodies that recognized recombinant and native gp120 but, consistent with the literature, the C4 peptide having no conformational constraints did not. The experimental results show that only those antibodies formed against a helical immunogen from C4 will recognize recombinant and native gp120, and, therefore, the results support the notion that C4 is an alpha-helix in gp120.
引用
收藏
页码:23918 / 23921
页数:4
相关论文
共 19 条
[1]  
CARDONNIER A, 1989, NATURE, V340, P571
[2]  
CEASE KB, 1987, P NATL ACAD SCI USA, V47, P4249
[3]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[4]   CHARACTERIZATION OF THE SECRETED, NATIVE GP120 AND GP160 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
KALYANARAMAN, VS ;
RODRIGUEZ, V ;
VERONESE, F ;
RAHMAN, R ;
LUSSO, P ;
DEVICO, AL ;
COPELAND, T ;
OROSZLAN, S ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) :371-380
[5]   INFLUENCE OF ADJUVANTS ON THE QUANTITY, AFFINITY, ISOTYPE AND EPITOPE SPECIFICITY OF MURINE ANTIBODIES [J].
KENNEY, JS ;
HUGHES, BW ;
MASADA, MP ;
ALLISON, AC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 121 (02) :157-166
[6]   LYMPHOCYTE-T T4 MOLECULE BEHAVES AS THE RECEPTOR FOR HUMAN RETROVIRUS LAV [J].
KLATZMANN, D ;
CHAMPAGNE, E ;
CHAMARET, S ;
GRUEST, J ;
GUETARD, D ;
HERCEND, T ;
GLUCKMAN, JC ;
MONTAGNIER, L .
NATURE, 1984, 312 (5996) :767-768
[7]   FUNCTIONAL REGIONS OF THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
KOWALSKI, M ;
POTZ, J ;
BASIRIPOUR, L ;
DORFMAN, T ;
WEI, CG ;
TERWILLIGER, E ;
DAYTON, A ;
ROSEN, C ;
HASELTINE, W ;
SODROSKI, J .
SCIENCE, 1987, 237 (4820) :1351-1355
[8]   DELINEATION OF A REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR [J].
LASKY, LA ;
NAKAMURA, G ;
SMITH, DH ;
FENNIE, C ;
SHIMASAKI, C ;
PATZER, E ;
BERMAN, P ;
GREGORY, T ;
CAPON, DJ .
CELL, 1987, 50 (06) :975-985
[9]  
LINDNER W, 1987, INT J PEPT PROT RES, V30, P794
[10]   BINDING OF HTLV-III/LAV TO T4+ T-CELLS BY A COMPLEX OF THE 110K VIRAL PROTEIN AND THE T4 MOLECULE [J].
MCDOUGAL, JS ;
KENNEDY, MS ;
SLIGH, JM ;
CORT, SP ;
MAWLE, A ;
NICHOLSON, JKA .
SCIENCE, 1986, 231 (4736) :382-385